Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 single-blind exploratory study of M2001 for diabetic neuropathy in adults with type 2 diabetes
MOH_2023-07-02_012785Phase 2Not yet recruiting
- Sponsor
- סינדרומאקס
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 2, single-blind, single-arm trial of M2001 in diabetic neuropathy and type 2 diabetes mellitus (T2DM), sponsored by סינדרומאקס. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
M2001
03
Conditions
diabetic neuropathytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on MOH_2023-07-02_012785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-07-02_012785.